Mélinda Charrier

2.4k citations
17 papers · 495 indexed · h-index 7
Topics
Cancer Immunotherapy and Biomarkers (9 papers)Immune Cell Function and Interaction (4 papers)Immunotherapy and Immune Responses (4 papers)
Partner nations
FranceSwitzerlandSpain

In The Last Decade

Mélinda Charrier

17 papers receiving 491 citations

Peers

Mélinda Charrier
Comparison fields: 5 of 50
  • Molecular Biology 249
  • Oncology 204
  • Immunology 179
  • Cancer Research 142
  • Epidemiology 70
Replace Emilia Andersson with:
Emilia Andersson Sweden
Kyriakos Chatzopoulos Greece
Tine S. Mantoni United Kingdom
Manami Shimomura Japan
Sabrina Carpentier France
Hillary Elwood United States
Francisco Expósito Spain
Kuo‐Chang Wen Taiwan
Joël Gsponer Switzerland
Benjamin Kansy Germany
Mélinda Charrier relative to Emilia Andersson Sweden Emilia Andersson's profile →
Citations per field
00.5×3.2×
Emilia Andersson · 1×
Citations per year

Countries citing papers authored by Mélinda Charrier

Since Specialization
Citations

This map shows the geographic impact of Mélinda Charrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélinda Charrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélinda Charrier more than expected).

Fields of papers citing papers by Mélinda Charrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélinda Charrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélinda Charrier. The network helps show where Mélinda Charrier may publish in the future.

Co-authorship network of co-authors of Mélinda Charrier

This figure shows the co-authorship network connecting the top 25 collaborators of Mélinda Charrier. A scholar is included among the top collaborators of Mélinda Charrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélinda Charrier. Mélinda Charrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 2
3 12
4 1
5 34
6 3
7 34
8 17
9 2
10 5
11 4
12 4
13 114
14 1
15 1
16 242
17 18

About Mélinda Charrier

Mélinda Charrier is a scholar working on Oncology, Immunology and Internal Medicine, having authored 17 papers that have together received 495 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Cancer Research (142 citations), Immunology (179 citations) and Oncology (204 citations). Mélinda Charrier has collaborated with scholars based in France, Switzerland and Spain. Frequent co-authors include Nathalie Chaput, Benjamin Besse, Jonathan M. Pitt, Sophie Viaud, Laurence Zitvogel, Fabrice André, Lydie Cassard, David Planchard, Lisa Boselli and Julien Adam. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026